NCT06512363View on ClinicalTrials.gov

A Study of Ramelteon in Chinese Patients With Chronic Insomnia

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Insomnia
Interventions
DRUG

Ramelteon

Ramelteon 8 mg, tablets, orally, once nightly for up to 5 weeks.

DRUG

Ramelteon placebo

Ramelteon placebo-matching tablets, orally, once nightly for up to 5 weeks.

Sponsors
All Listed Sponsors
lead

Nanjing Chia-tai Tianqing Pharmaceutical

INDUSTRY